Sphingomab
Sphingomab (sonepcizumab), generated by Lpath's proprietary ImmuneY2 platform technology, is a humanized monoclonal antibody against the bioactive lipid S1P (sphingosine-1-phosphate).
Derivation: Human
Type: scFv
Application: FC, IP, FuncS
Compare
Derivation: Human
Type: IgG
Application: FC, ELISA, FuncS
Compare
Derivation: Human
Type: Fab
Application: FC, ELISA, FuncS
Compare
Derivation: Mouse
Type: scFv
Application: Neut, IF, FuncS
Compare
Derivation: Mouse
Type: Fab
Application: WB, IP, FuncS
Compare
Derivation: Mouse
Type: IgG
Application: ELISA, WB, FC, FuncS
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.